PDE10A inhibitors (Amgen)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NamePDE10A inhibitors (Amgen)
Drug Alias NameAMG-579 analogs (Amgen)
ClassificationSmall molecules
Mechanisms of ActionPhosphodiesterase 10A inhibitorsCNS modulatorsType 2 cyclic nucleotide phosphodiesterases inhibitors
TargetsPhosphodiesterase 10AType 2 cyclic nucleotide phosphodiesterases
Therapy Area/IndicationsNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAmgen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmgen Inc
Active IndicationsN/A
Inactive IndicationsNervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A